NYSEAMERICAN:TRXC - TransEnterix Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$4.08
▼ -0.46 (-10.13%)
1 month | 3 months | 12 months
Get New TransEnterix Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRXC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRXC

Average Price Target: $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for TransEnterix in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $4.08.

Hold

The current consensus among 2 investment analysts is to hold stock in TransEnterix. This rating has held steady since June 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/20/2021LADENBURG THALM/SH SHReiterated RatingBuy ➝ Neutral
11/9/2020Raymond JamesReiterated RatingHold
8/16/2020Raymond JamesReiterated RatingHold
8/8/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$1.00
5/22/2019Piper Jaffray CompaniesInitiated CoverageNeutral$1.60
5/14/2019BTIG ResearchUpgradeNeutral ➝ Buy$3.00
11/9/2018LADENBURG THALM/SH SHUpgradeNeutral ➝ Buy$5.00
9/25/2018BTIG ResearchReiterated RatingHold
7/5/2018Stifel NicolausReiterated RatingBuy$5.50
6/28/2018BTIG ResearchDowngradeBuy ➝ Neutral
5/29/2018LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$3.50 ➝ $4.00
5/9/2018BTIG ResearchUpgradeNeutral ➝ Buy
12/18/2017BTIG ResearchReiterated RatingHold
10/31/2017Stifel NicolausBoost Price TargetBuy$3.75 ➝ $4.00
10/30/2017Stifel NicolausReiterated RatingBuy ➝ Buy$3.75 ➝ $4.00
10/20/2017LADENBURG THALM/SH SHSet Price TargetBuy$5.00
5/16/2017B. RileyDowngradeNeutral$0.70
5/11/2017B. RileyDowngradeBuy ➝ Neutral$0.70
3/12/2017B. RileyReiterated RatingBuy$2.75
3/7/2017B. RileyReiterated RatingBuy$2.75
1/19/2017Raymond JamesDowngradeOutperform ➝ Mkt Perform
11/15/2016B. RileyReiterated RatingBuy$3.00
11/10/2016B. RileyReiterated RatingBuy$3.00
10/11/2016B. RileyInitiated CoverageBuy$3.00
10/7/2016B. RileyReiterated RatingBuy
10/7/2016B. RileyInitiated CoverageBuy$3.00
10/6/2016B. RileyInitiated CoverageBuy$3.00
(Data available from 6/21/2016 forward)
TransEnterix logo
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $4.08
Low: $3.62
High: $4.77

50 Day Range

MA: $0.49
Low: $0.36
High: $1.17

52 Week Range

Now: $4.08
Low: $0.28
High: $6.95

Volume

37,554,301 shs

Average Volume

44,558,918 shs

Market Capitalization

$582.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.56

Frequently Asked Questions

What sell-side analysts currently cover shares of TransEnterix?

The following Wall Street sell-side analysts have issued stock ratings on TransEnterix in the last year: LADENBURG THALM/SH SH, Raymond James, and Zacks Investment Research.
View the latest analyst ratings for TRXC.

What is the current price target for TransEnterix?

0 Wall Street analysts have set twelve-month price targets for TransEnterix in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for TransEnterix in the next year.
View the latest price targets for TRXC.

What is the current consensus analyst rating for TransEnterix?

TransEnterix currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TRXC, but not buy more shares or sell existing shares.
View the latest ratings for TRXC.

What other companies compete with TransEnterix?

How do I contact TransEnterix's investor relations team?

TransEnterix's physical mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier's listed phone number is +1-919-7658400 and its investor relations email address is [email protected] The official website for TransEnterix is www.transenterix.com.